6556 Journal of Medicinal Chemistry, 2008, Vol. 51, No. 20
Cowart et al.
(4) (a) Esbenshade, T. A.; Browman, K. E.; Bitner, R. S.; Strakhova, M.;
Cowart, M. D.; Brioni, J. D. The histamine H3 receptor: an attractive
target for the treatment of cognitive disorders. Br. J. Pharmacol. 2008,
154, 1166–1181. (b) Esbenshade, T. A.; Fox, G. B.; Cowart, M. D.
Histamine H3 receptor antagonists: preclinical promise for treating
obesity and cognitive disorders. Mol. InterVentions 2006, 6 (2), 77–
88.
(5) Celanire, S.; Wijtmans, M.; Talaga, P.; Leurs, R.; de Esch, I. J. P.
Histamine H3receptor antagonists reach out for the clinic. Drug
DiscoVery Today 2005, 10 (23/24), 1613–1627.
(6) Morse, K. L.; Behan, J.; Laz, T. M.; West, R. E.; Greenfeder, S. A.;
Anthes, J. C.; Umland, S.; Wan, Y.; Hipkin, R. W.; Gonsiorek, W.;
Shin, N.; Gustafson, E. L.; Qiao, X.; Wang, S.; Hedrick, J. A.; Greene,
J.; Bayne, M.; Monsma, F. J., Jr. Cloning and characterization of a
novel human histamine receptor. J. Pharmacol. Exp. Ther 2001, 296,
1058–1066.
(7) Oda, T.; Morikawa, N.; Saito, Y.; Masuho, Y.; Matsumoto, S.-i.
Molecular cloning and characterization of a novel type of histamine
receptor preferentially expressed in leukocytes. J. Biol. Chem. 2000,
275, 36781–36786.
(8) Nakamura, T.; Itadani, H.; Hidaka, Y.; Ohta, M.; Tanaka, K. Molecular
cloning and characterization of a new human histamine receptor,
HH4R. Biochem. Biophys. Res. Commun. 2000, 279, 615–620.
(9) Zhu, Y.; Michalovich, D.; Wu, H.-L.; Tan, K. B.; Dytko, G. M.;
Mannan, I. J.; Boyce, R.; Alston, J.; Tierney, L. A.; Li, X.; Herrity,
N. C.; Vawter, L.; Sarau, H. M.; Ames, R. S.; Davenport, C. M.;
Hieble, J. P.; Wilson, S.; Bergsma, D. J.; Fitzgerald, L. R. Cloning,
expression, and pharmacological characterization of a novel human
histamine receptor. Mol. Pharmacol. 2001, 59, 434–441.
(10) Nguyen, T.; Shapiro, D. A.; George, S. R.; Setola, V.; Lee, Dennis,
K.; Cheng, R.; Rauser, L.; Lee, S. P.; Lynch, K. R.; Roth, B. L.;
O’Dowd, B. F. Discovery of a novel member of the histamine receptor
family. Mol. Pharmacol. 2001, 59, 427–433.
(11) Liu, C.; Ma, X.-J.; Jiang, X.; Wilson, S. J.; Hofstra, C. L.; Blevitt, J.;
Pyati, J.; Li, X.; Chai, W.; Carruthers, N.; Lovenberg, T. W. Cloning
and pharmacological characterization of a fourth histamine receptor
(H4) expressed in bone marrow. Mol. Pharmacol. 2001, 59, 420–426.
(12) Coge, F.; Guenin, S.-P.; Rique, H.; Boutin, J. A.; Galizzi, J.-P. Structure
and expression of the human histamine H4-receptor gene. Biochem.
Biophys. Res. Commun. 2001, 284, 301–309.
(13) O’Reilly, M.; Alpert, R.; Jenkinson, S.; Gladue, R. P.; Foo, S.; Trim,
S.; Peter, B.; Trevethick, M.; Fidock, M. Identification of a histamine
H4 receptor on human eosinophils. Role in eosinophil chemotaxis. J.
Recept. Signal Transduction 2002, 22 (1-4), 431–448.
(14) Damaj, B. B.; Becerra, C. B.; Esber, H. J.; Wen, Y.; Maghazachi,
A. A. Functional expression of H4 histamine receptor in human natural
killer cells, monocytes, and dendritic cells. J. Immunol. 2007, 179,
7907–7915.
(15) Zhang, M.; Thurmond, R. L.; Dunford, P. J. The histamine H4 receptor:
a novel modulator of inflammatory and immune disorders. Pharmacol.
Ther. 2007, 113, 594–606.
(16) Thurmond, R. L.; Gelfand, E. W.; Dunford, P. J. The role of histamine
H1 and H4 receptors in allergic inflammation: the search for new
antihistamines. Nat. ReV. Drug DiscoVery 2008, 7, 41–53.
(17) Ling, P.; Ngo, K.; Nguyen, S.; Thurmond, R. L.; Edwards, J. P.;
Karlsson, L.; Fung-Leung, W. P. Histamine H4 receptor mediates
eosinophil chemotaxis with cell shape change and adhesion molecule
upregulation. Br. J. Pharmacol. 2004, 142, 161–171.
J. P.; Baker, S. J.; Wetter, J. M.; Marsh, K. C.; Hancock, A. A.;
Decker, M. W.; Cowart, M. D.; Esbenshade, T. A.; Brioni, J. D.;
Honore, P. Histamine H4 receptor as a potential antinociceptive
target: effects of a potent and selective H4 antagonist in animal
pain models. Manuscript submitted for publication.
(25) Altenbach, R. J.; Adair, R. M.; Bettencourt, B. M.; Black, L. A.; Fix-
Stenzel, S. R.; Gopalakrishnan, S. M.; Hsieh, G. C.; Liu, H.; Marsh,
K. C.; McPherson, M. J.; Milicic, I.; Miller, T. R.; Warrior, U.; Wetter,
J. M.; Wishart, N.; Witte, D. G.; Esbenshade, T. A.; Hancock, A. A.;
Brioni, J. D.; Cowart, M. D. SAR studies on a series of a 2-aminopy-
rimidine containing histamine H4 receptor ligands. J. Med. Chem., in
press.
(26) Coruzzi, G.; Adami, M.; Guaita, E.; de Esch, I. J. P.; Leurs, R.
Antiinflammatory and antinociceptive effects of the selective histamine
H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of
carrageenan-induced acute inflammation. Eur. J. Pharmacol. 2007,
563, 240–244.
(27) Jablonowski, J. A.; Grice, C. A.; Chai, W.; Dvorak, C. A.; Venable,
J. D.; Kwok, A. K.; Ly, K. S.; Wei, J.; Baker, S. M.; Desai, P. J.;
Jiang, W.; Wilson, S. J.; Thurmond, R. L.; Karlsson, L.; Edwards,
J. P.; Lovenberg, T. W.; Carruthers, N. I. The first potent and selective
non-imidazole human histamine H4 receptor antagonists. J. Med. Chem.
2003, 46, 3957–3960.
(28) Liu, C.; Wilson, S. J.; Kuei, C.; Lovenberg, T. W. Comparison of
human, mouse, rat, and guinea pig histamine H4 receptors reveals
substantial pharmacological species variation. J. Pharmacol. Exp. Ther.
2001, 299, 121–130.
(29) Oda, T.; Matsumoto, S.i.; Matsumoto, M.; Takasaki, J.; Kamohara,
M.; Soga, T.; Hiyama, H.; Kobori, M.; Katoh, M. Molecular cloning
of monkey histamine H4 receptor. J. Pharmacol. Sci 2005, 98, 319–
322.
(30) (a) Esbenshade, T. A.; Fox, G. B.; Krueger, K. M.; Baranowski, J. L.;
Miller, T. R.; Kang, C. H.; Denny, L. I.; Witte, D. G.; Yao, B. B.;
Pan, J. B.; Faghih, R.; Bennani, Y. L.; Williams, M.; Hancock, A. A.
Pharmacological and behavioral properties of A-349821, a selective
and potent human histamine H3 receptor antagonist. Biochem. Phar-
macol. 2004, 68, 933–945. (b) Esbenshade, T. A.; Krueger, K. M.;
Miller, T. R.; Kang, C. H.; Denny, L. I.; Witte, D. G.; Yao, B. B.;
Fox, G. B.; Faghih, R.; Bennani, Y. L.; Williams, M.; Hancock, A. A.
Two novel and selective nonimidazole histamine H3 receptor antago-
nists A-304121 and A-317920: I. In vitro pharmacological effects.
J. Pharmacol. Exp. Ther. 2003, 305, 887–896.
(31) Cowart, M.; Faghih, R.; Curtis, M. P.; Gfesser, G. A.; Bennani, Y,
L.; Black, L. A.; Pan, L.; Marsh, K. C.; Sullivan, J. P.; Esbenshade,
T. A.; Fox, G. B.; Hancock, A. A. (2-(2(R)-Methyl-pyrrolidine-1-
yl)ethyl)benzofuran-5-yl)-benzonitrile (ABT-239) and related 2-ami-
noethylbenzofuran H3 antagonists potently enhance cognition and
attention. J. Med. Chem. 2005, 48, 38–55.
(32) Veber, D. F.; Johnson, S. R.; Chen, H.-Y.; Smith, B. R.; Ward, K. W.;
Kopple, K. D. Molecular properties that influence the oral bioavail-
ability of drug candidates. J. Med. Chem. 2002, 45, 2615–2623.
(33) Wenlock, M. C.; Austin, R. P.; Barton, P.; Davis, A. M.; Leeson,
P. D. A comparison of physiochemical property profiles of develop-
ment and marketed oral drugs. J. Med. Chem. 2003, 46, 1250–1256.
(34) Compounds were tested for inhibition of CYP-3A4, -2D6, and -2C9
at up to 10 µM concentration.
(35) Chazot, P.; Connelly, W.; Shenton, F. C.; Lethbridge, N.; van Renburg,
R.; Lees, G. Further Evidence for H4 Histamine Receptor Expression
on Central Neurons. Presented at the Meeting of the European
Histamine Research Society, 2006; O6.
(18) Buckland, K. F.; Williams, T. J.; Conroy, D. M. Histamine induces
cytoskeletal changes in human eosinophils via the H4 receptor. Br. J.
Pharmacol. 2003, 140, 1117–1127.
(36) (a) Pajouhesh, H.; Lenz, G. R. Medicinal chemical properties of
successful central nervous system drugs. NeuroRx: J. Am. Soc. Exp.
NeuroTher. 2005, 2, 541–553. (b) Parepally, J. M. R.; Mandula,
H.; Smith, Q. R. Brain Uptake of Nonsteroidal Anti-Inflammatory
Drugs: Ibuprofen, Flurbiprofen, and Indomethacin. Pharm. Res.
2006, 23, 873–881. (c) Parepally, J. M. R. Factors Limiting Non-
Steroidal Anti-Inflammatory Drug Uptake and Distribution in
Central Nervous System. Ph.D. Thesis, Texas Tech University,
Lubbock, TX, 2005(Texas Digital Library, University of Texas at
Austin, Austin, TX, http://repositories.tdl.org/handle/2346/1148).
(37) Kim, S. H.; Chung, J. M. An experimental model for peripheral
neuropathy produced by segmental spinal nerve ligation in the rat.
Pain 1992, 50, 355–363.
(19) Thurmond, R. L.; Desai, P. J.; Dunford, P. J.; Fung-Leung, W. P.;
Hofstra, C. L.; Jiang, W.; Nguyen, S.; Riley, J. P.; Sun, S.; Williams,
K. N.; Edwards, J. P.; Karlsson, L. A potent and selective histamine
H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol.
Exp. Ther. 2004, 309, 404–413.
(20) Dunford, P. J.; O’Donnell, N.; Riley, J. P.; Williams, K. N.; Karlsson,
L.; Thurmond, R. L. The histamine H4 receptor mediates allergic
airway inflammation by regulating the activation of CD4+ T cells.
J. Immunol. 2006, 176, 7062–7070.
(21) Varga, C.; Horvath, K.; Berko, A.; Thurmond, R. L.; Dunford, P. J.;
Whittle, B. J. R. Inhibitory effects of histamine H4 receptor antagonists
on experimental colitis in the rat. Eur. J. Pharmacol. 2005, 522, 130–
138.
(38) Hofstra, C. L.; Desai, P. J.; Thurmond, R. L.; Fung-Leung, W.-P.
Histamine H4 receptor mediates chemotaxis and calcium mobilization
of mast cells. J. Pharmacol. Exp. Ther. 2003, 305, 1212–1221.
(39) Barnard, R.; Barnard, A.; Salmon, G.; Liu, W.; Sreckovic, S.
Histamine-induced actin polymerization in human eosinophils: an
imaging approach for histamine H4 receptor. Cytometry (Part A) 2008,
73, 299–304.
(22) Bell, J. K.; McQueen, D. S.; Rees, J. L. Involvement of histamine H4
and H1 receptors in scratching induced by histamine receptor agonists
in balb C mice. Br. J. Pharmacol. 2004, 142, 374–380.
(23) Dunford, P. J.; Williams, K. N.; Desai, P. J.; McQueen, D.; Karlsson,
L.; Thurmond, R. Histamine H4 receptor antagonists are superior to
traditional antihistamines in the attenuation of experimental pruritus.
J. Allergy Clin. Immunol. 2007, 119, 176–183.
(24) Hsieh, G. C.; Chandran, P.; Salyers, A. K.; Pai, M.; Zhu, C. Z.;
Wensink, E. J.; Witte, D. G.; Miller, T. R.; Milicic, I.; Mikusa,
(40) Ikawa, Y.; Suzuki, M.; Shiono, S.; Ohki, E.; Moriya, H.; Nigishi, E.;
Ueno, K. Histamine H4 receptor expression in human synovial cells